Description

BSE announces listing of new Commercial Papers worth Rs. 50 crores issued by Manappuram Finance Limited on private placement basis, effective December 15, 2025.

Summary

BSE has listed two tranches of Commercial Papers issued by Manappuram Finance Limited on private placement basis, totaling Rs. 50 crores. The securities are listed on the BSE Debt segment effective December 15, 2025. Both instruments carry CARE A1+ and CRISIL A1+ ratings and will be traded only in dematerialized form with Axis Bank Limited as the Issuing and Paying Agent.

Key Points

  • First tranche: 6,000 units of Rs. 5,00,000 each (total Rs. 30 crores), Scrip Code 729273, ISIN INE522D14OJ4
  • Second tranche: 4,000 units of Rs. 5,00,000 each (total Rs. 20 crores), Scrip Code 730766, ISIN INE522D14PC6
  • Both tranches rated CARE A1+ and CRISIL A1+
  • Issuing and Paying Agent: Axis Bank Limited
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Market lot: 1 unit

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for new debt securities.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form
  • Trading must be done in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members requiring clarification should contact BSE debt department at 22728352/8597/8995/5753/8915

Important Dates

  • Allotment Date (Tranche 1 & 2): December 12, 2025
  • Listing Date: December 15, 2025
  • Redemption Date (Tranche 1): March 13, 2026
  • Redemption Date (Tranche 2): March 10, 2026

Impact Assessment

Minimal market impact. This is a routine listing of short-term debt instruments (commercial papers) with maturity of approximately 90 days. The instruments are rated A1+ by both CARE and CRISIL, indicating high credit quality. The listing provides additional short-term funding options for Manappuram Finance Limited and investment opportunities for debt market participants. No impact on equity markets or broader trading operations.

Impact Justification

Routine debt instrument listing with no impact on equity markets or broader market operations